Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline
ELKRIDGE, MD. (PRWEB) DECEMBER 27, 2019 Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline that offers patients and healthcare providers options in the treatment of chronic diseases that disproportionately affect geriatric patients. The products concepts were identified in collaboration with doctors and managed care professionals and developed at Vici’s R&D […]